Pediatric Cardiology

, Volume 39, Issue 5, pp 906–910 | Cite as

22q11.2 Deletion Status and Perioperative Outcomes for Tetralogy of Fallot with Pulmonary Atresia and Multiple Aortopulmonary Collateral Vessels

  • Laura Mercer-Rosa
  • Okan U. Elci
  • Nelangi M. Pinto
  • Ronn E. Tanel
  • Elizabeth Goldmuntz
Original Article

Abstract

Deletion of 22q11.2 (del22q11) is associated with adverse outcomes in patients with tetralogy of Fallot (TOF). We sought to investigate its contribution to perioperative outcome in patients with a severe form of TOF characterized by pulmonary atresia (PA) or severe pulmonary stenosis (PS) and major aortopulmonary collateral arteries (MAPCAS). We conducted a retrospective review of patients with TOF/MAPCAS who underwent staged surgical reconstruction between 1995 and 2006. Groups were compared according to 22q11.2 deletion status using t-tests or the Wilcoxon Rank sum test. We included 26 subjects, 24 of whom survived the initial operation. Of those, 21 subjects had known deletion status and constitute the group for this analysis [15 with no deletion present (ND) and 6 del22q11 subjects]. There was no difference with respect to occurrence of palliative procedure prior to initial operation, or to timing of closure of the ventricular septal defect (VSD). Other than higher prevalence of prematurity (50%) in the del22q11 group versus no prematurity in the ND, the groups were comparable in terms of pre-operative characteristics. The intra- and post-operative course outcomes (length of cardiopulmonary bypass, use of vasopressors, duration of intensive care and length of hospital stay, tube-feeding) were also comparable. Although the del22q11 had longer mechanical ventilation than the ND, this difference was not significant [68 h (range 4–251) vs. 45 h (range 3–1005), p = 0.81]. In this detailed comparison of a small patient cohort, 22q11.2 deletion syndrome was not associated with adverse perioperative outcomes in patients with TOF, PA, and MAPCAS when compared to those without 22q11.2 deletion syndrome. These results are relevant to prenatal and neonatal pre-operative counseling and planning.

Keywords

Tetralogy of Fallot DiGeorge syndrome 22q11.2 deletion Aortopulmonary collateral vessels Outcome 

Notes

Acknowledgements

We would like to thank Sharon M. Edman, MS, for her extensive work in data organization and management.

Compliance with Ethical Standards

Conflict of interest

Laura Mercer-Rosa, Okan U. Elci, Nelangi M. Pinto, Ronn E. Tanel and Elizabeth Goldmuntz declare that they have no conflict of interest.

References

  1. 1.
    Carotti A, Albanese SB, Filippelli S, Rava L, Guccione P, Pongiglione G, Di Donato RM (2010) Determinants of outcome after surgical treatment of pulmonary atresia with ventricular septal defect and major aortopulmonary collateral arteries. J Thorac Cardiovasc Surg 140:1092–1103CrossRefPubMedGoogle Scholar
  2. 2.
    Ishibashi N, Shin’oka T, Ishiyama M, Sakamoto T, Kurosawa H (2007) Clinical results of staged repair with complete unifocalization for pulmonary atresia with ventricular septal defect and major aortopulmonary collateral arteries. Eur J Cardiothorac Surg 32:202–208CrossRefPubMedGoogle Scholar
  3. 3.
    Trainer AH, Morrison N, Dunlop A, Wilson N, Tolmie J (1996) Chromosome 22q11 microdeletions in tetralogy of Fallot. Arch Dis Child 74:62–63CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Takahashi K, Kido S, Hoshino K, Ogawa K, Ohashi H, Fukushima Y (1995) Frequency of a 22q11 deletion in patients with conotruncal cardiac malformations: a prospective study. Eur J Pediatr 154:878–881CrossRefPubMedGoogle Scholar
  5. 5.
    Peyvandi S, Lupo PJ, Garbarini J, Woyciechowski S, Edman S, Emanuel BS, Mitchell LE, Goldmuntz E (2013) 22q11.2 deletions in patients with conotruncal defects: data from 1,610 consecutive cases. Pediatr Cardiol 34:1687–1694CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Goldmuntz E, Driscoll D, Budarf ML, Zackai EH, McDonald-McGinn DM, Biegel JA, Emanuel BS (1993) Microdeletions of chromosomal region 22q11 in patients with congenital conotruncal cardiac defects. J Med Genet 30:807–812CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Amati F, Mari A, Digilio MC, Mingarelli R, Marino B, Giannotti A, Novelli G, Dallapiccola B (1995) 22q11 deletions in isolated and syndromic patients with tetralogy of Fallot. Hum Genet 95:479–482CrossRefPubMedGoogle Scholar
  8. 8.
    Mahle WT, Crisalli J, Coleman K, Campbell RM, Tam VK, Vincent RN, Kanter KR (2003) Deletion of chromosome 22q11.2 and outcome in patients with pulmonary atresia and ventricular septal defect. Ann Thorac Surg 76:567–571CrossRefPubMedGoogle Scholar
  9. 9.
    van Dongen EI, Glansdorp AG, Mildner RJ, McCrindle BW, Sakopoulos AG, VanArsdell G, Williams WG, Bohn D (2003) The influence of perioperative factors on outcomes in children aged less than 18 months after repair of tetralogy of Fallot. J Thorac Cardiovasc Surg 126:703–710CrossRefPubMedGoogle Scholar
  10. 10.
    Doell C, Bernet V, Molinari L, Beck I, Balmer C, Latal B (2011) Children with genetic disorders undergoing open-heart surgery: are they at increased risk for postoperative complications? Pediatr Crit Care Med 12:539–544CrossRefPubMedGoogle Scholar
  11. 11.
    Mercer-Rosa L, Pinto N, Yang W, Tanel R, Goldmuntz E (2013) 22q11.2 Deletion syndrome is associated with perioperative outcome in tetralogy of Fallot. J Thorac Cardiovasc Surg 146:868–873CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Goldenberg RL, Culhane JF, Iams JD, Romero R (2008) Epidemiology and causes of preterm birth. Lancet 371:75–84CrossRefPubMedGoogle Scholar
  13. 13.
    Tanner K, Sabrine N, Wren C (2005) Cardiovascular malformations among preterm infants. Pediatrics 116:e833–e838CrossRefPubMedGoogle Scholar
  14. 14.
    Bauser-Heaton H, Borquez A, Han B, Ladd M, Asija R, Downey L, Koth A, Algaze CA, Wise-Faberowski L, Perry SB, Shin A, Peng LF, Hanley FL, McElhinney DB (2017) Programmatic approach to management of tetralogy of Fallot With major aortopulmonary collateral arteries: a 15-year experience with 458 patients. Circ Cardiovasc Interv 10(4):e004952CrossRefPubMedGoogle Scholar
  15. 15.
    McDonald R, Dodgen A, Goyal S, Gossett JM, Shinkawa T, Uppu SC, Blanco C, Garcia X, Bhutta AT, Imamura M, Gupta P (2013) Impact of 22q11.2 deletion on the postoperative course of children after cardiac surgery. Pediatr Cardiol 34:341–347CrossRefPubMedGoogle Scholar
  16. 16.
    Asija R, Koth AM, Velasquez N, Chan FP, Perry SB, Hanley FL, McElhinney D (2016) Postoperative outcomes of children with tetralogy of Fallot, pulmonary atresia, and major aortopulmonary collaterals undergoing reconstruction of occluded pulmonary artery branches. Ann Thorac Surg 101:2329–2334CrossRefPubMedGoogle Scholar
  17. 17.
    O’Byrne ML, Yang W, Mercer-Rosa L, Parnell AS, Oster ME, Levenbrown Y, Tanel RE, Goldmuntz E (2014) 22q11.2 Deletion syndrome is associated with increased perioperative events and more complicated postoperative course in infants undergoing infant operative correction of truncus arteriosus communis or interrupted aortic arch. J Thorac Cardiovasc Surg 148:1597–1605CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Mercer-Rosa L, Paridon SM, Fogel MA, Rychik J, Tanel RE, Zhao H, Zhang X, Yang W, Shults J, Goldmuntz E (2015) 22q11.2 deletion status and disease burden in children and adolescents with tetralogy of Fallot. Circ Cardiovasc Genet 8:74–81CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Chessa M, Butera G, Bonhoeffer P, Iserin L, Kachaner J, Lyonnet S, Munnich A, Sidi D, Bonnet D (1998) Relation of genotype 22q11 deletion to phenotype of pulmonary vessels in tetralogy of Fallot and pulmonary atresia-ventricular septal defect. Heart 79:186–190CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Division of Cardiology, Department of PediatricsThe Children’s Hospital of Philadelphia and Perelman School of Medicine at the University of PennsylvaniaPhiladelphiaUSA
  2. 2.Westat-Biostatistics and Data Management CoreThe Children’s Hospital of PhiladelphiaPhiladelphiaUSA
  3. 3.Division of Pediatric Cardiology, Department of PediatricsUniversity of UtahSalt Lake CityUSA
  4. 4.Department of Pediatric CardiologyUniversity of California, San FranciscoSan FranciscoUSA

Personalised recommendations